While Pacific BioLabs is often collaborating with clients to develop and validate methods for the analysis of new drug candidates, their Analytical Department also has considerable experience analyzing for common reagents, generic pharmaceuticals or older drugs that have been marketed for many years. Pacific BioLabs offers several platforms (HPLC/UV, LC/MS, GC/MS, GC/FID, ELISA) for analysis, so whether you are conducting residue analysis for an antibiotic like kanamycin, or for a drug-drug interaction study, Pacific BioLabs likely has analytical experience with your compound or for an analog in the same chemical class.
The table below details a partial list of compounds for which Pacific BioLabs has analytical familiarity. Based on the compound, the matrix, and the sensitivity requirements, analytical and bioanalytical methods have been developed and qualified at Pacific BioLabs utilizing appropriate techniques. Analysis methods for these compounds can be quickly tailored to your sample matrix for reduced cost and faster development time.
Table: Partial list of compounds for which PBL has developed analytical methods.